Search results
Results from the WOW.Com Content Network
Pyrantel pamoate is considered a pregnancy category C drug for use during pregnancy for humans, but is in category A for canines and felines. Pyrantel is considered safe to use in nursing animals. [7]
The pregnancy category of a medication is an assessment of the risk of fetal injury due to the pharmaceutical, if it is used as directed by the mother during pregnancy. It does not include any risks conferred by pharmaceutical agents or their metabolites in breast milk .
ATC code P02 Anthelmintics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
The available data on mebendazole, albendazole, and pyrantel pamoate use in pregnancy is limited and they are all assigned to pregnancy category level C. Treatment of a pinworm infection during pregnancy is only recommended for patients with significant symptoms that may be causing adverse effects to the pregnant woman such as loss of sleep and ...
Category should be empty, note that one can always use any-text input in |pregnancy_AU_comment=, |pregnancy_US_comment=. This template is used on many pages and changes may be widely noticed. Test changes in the template's or subpages, or in your own user subpage .
The FDA pregnancy classification is removed from this infobox, and does not show any more. By FDA, it is replaced by the Pregnancy and Lactation Labeling Rule (PLLR) of December 2014. The PLLR is descriptive, and not suitable for this infobox. [1]
The WHO Model List of Essential Medicines for Children (aka Essential Medicines List for Children [1] or EMLc [1]), published by the World Health Organization (WHO), contains the medications considered to be most effective and safe in children up to twelve years of age to meet the most important needs in a health system.
While use in pregnancy does not appear to be harmful, such use has not been well studied. [7] Aprepitant belongs to the class of neurokinin-1 receptor antagonists. [5] It works by blocking substance P from attaching to the NK 1 receptors. [4] Aprepitant was approved for medical use in the European Union and the United States in 2003.